Norton Rose Faces Renewed DQ Bid In Pamlab Suit
Virtus Pharmaceuticals LLC refused Friday to drop its attempt to block Norton Rose Fulbright from representing Nestle Health Science-Pamlab Inc. in its unfair competition suit seeking to keep Virtus from selling...To view the full article, register now.
Already a subscriber? Click here to view full article